SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-034146
Filing Date
2023-12-12
Accepted
2023-12-12 09:19:07
Documents
17
Period of Report
2023-12-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sava20231211_8k.htm   iXBRL 8-K 35371
2 EXHIBIT 99.1 ex_605372.htm EX-99.1 21341
3 EXHIBIT 99.2 ex_605373.htm EX-99.2 44123
8 ex_605372img001.jpg GRAPHIC 10606
9 ex_605373img001.jpg GRAPHIC 7781
  Complete submission text file 0001437749-23-034146.txt   276815

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sava-20231212.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sava-20231212_def.xml EX-101.DEF 11425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sava-20231212_lab.xml EX-101.LAB 15311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sava-20231212_pre.xml EX-101.PRE 11585
11 EXTRACTED XBRL INSTANCE DOCUMENT sava20231211_8k_htm.xml XML 2600
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 231480125
SIC: 2834 Pharmaceutical Preparations